UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 1904 - 1911
pembrolizumab | autoimmune | nivolumab | elderly | ipilimumab | pediatrics | pregnancy | transplant | organ dysfunction | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Melanoma - complications | Age Factors | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis C, Chronic - complications | Transplant Recipients | Neoplasms - complications | Brain Neoplasms - secondary | Squamous Cell Carcinoma of Head and Neck | Pregnancy Complications, Neoplastic - drug therapy | Female | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - complications | Graft Rejection - prevention & control | Autoimmune Diseases - complications | Head and Neck Neoplasms - drug therapy | Brain Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Pregnancy | Carcinoma, Non-Small-Cell Lung - complications | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Squamous Cell - drug therapy | Hepatitis B, Chronic - complications | Carcinoma, Squamous Cell - complications | Melanoma - drug therapy | Nivolumab | HIV Infections - complications | Head and Neck Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Renal Cell - complications | Immunocompromised Host | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Virus diseases | Care and treatment | Dosage and administration | Research | Cell death | Immunosuppressive agents | Medical research | Brain | Populations | Toxicity | Decision making | Mortality | Disorders | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Patients | Regulatory approval | Metastases | Inhibitors | Immune checkpoint | Aggregates | Lymphocytes | Safety | Autoimmune diseases | Cancer | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 9, pp. 1566 - 1575
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1778 - 1790
human papillomavirus (HPV) | tumor necrosis factor receptor‐associated factor 3 (TRAF3) | prognosis | nuclear factor κB (NF‐κB) | head and neck squamous cell carcinoma | nuclear factor κB (NF-κB) | tumor necrosis factor receptor-associated factor 3 (TRAF3) | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - genetics | Papillomavirus Infections - complications | Head and Neck Neoplasms - virology | Prognosis | Deubiquitinating Enzyme CYLD | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - virology | Humans | NF-kappa B - metabolism | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - metabolism | Oropharyngeal Neoplasms - complications | Papillomavirus Infections - genetics | Squamous Cell Carcinoma of Head and Neck | Papillomavirus Infections - metabolism | TNF Receptor-Associated Factor 3 - genetics | Carcinoma, Squamous Cell - complications | Tumor Suppressor Proteins - genetics | Oropharyngeal Neoplasms - metabolism | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Papillomaviridae | Databases, Factual | Complications and side effects | Chemotherapy | Usage | Head and neck cancer | Diagnosis | Radiotherapy | Papillomavirus infections | Health aspects | Risk factors | Smoking | Cancer | Epidemics | Correlation | Genes | Radiation | Clinical trials | Genomes | Cancer therapies | Carcinogenesis | Defects | Incidence | Metastases | Carcinogens | Human papillomavirus | Etiology | Transcription activation | Tumorigenesis | Medical research | Integration | Head | Squamous cell carcinoma | Data processing | Oropharynx | Radiation therapy | Patients | Survival | Morbidity | Radiation dosage | Side effects | Tobacco | Lysine | Medical prognosis | Biomarkers | Head & neck cancer | Mutation | Cervical cancer | Tumors | Index Medicus | Abridged Index Medicus | Original
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2020, Volume 382, Issue 1, pp. 60 - 72
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Papillomavirus Infections - complications | Prognosis | Humans | Head and Neck Neoplasms - therapy | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - diagnosis | Antineoplastic Agents - therapeutic use | Neoplasm Staging | Chemoradiotherapy | Head and Neck Neoplasms - pathology
Journal Article
2000, ISBN 9780309068833, ix, 218
Book
Annals of oncology, ISSN 0923-7534, 10/2010, Volume 21, Issue 7, pp. vii243 - vii245
Head and neck cancer | Survival | Mouth | Risk factors | HPV | Oropharyngx | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms, Squamous Cell - complications | Genetic Testing | Head and Neck Neoplasms - virology | Prognosis | Neoplasms, Squamous Cell - epidemiology | Humans | Carcinoma - virology | DNA, Viral - isolation & purification | Neoplasms, Squamous Cell - prevention & control | Neoplasms, Squamous Cell - virology | Papillomavirus Infections - diagnosis | Papillomavirus Infections - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma - complications | Carcinoma - epidemiology | Head and Neck Neoplasms - epidemiology | Papillomaviridae - physiology | Head and Neck Neoplasms - prevention & control | Papillomavirus Infections - complications | Papillomavirus Vaccines - therapeutic use | Papillomavirus Infections - epidemiology | Carcinoma - prevention & control | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Oropharyngeal Neoplasms - complications | Carcinoma, Squamous Cell | Oropharyngeal Neoplasms - epidemiology | Head and Neck Neoplasms - complications | Index Medicus
Journal Article
Auris, nasus, larynx, ISSN 0385-8146, 2016, Volume 44, Issue 1, pp. 98 - 103
Otolaryngology | Inverted papilloma | Squamous cell carcinoma | Sinonasal tract | Life Sciences & Biomedicine | Otorhinolaryngology | Science & Technology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Nose Neoplasms - complications | Neoplasms, Multiple Primary - therapy | Nose Neoplasms - diagnostic imaging | Aged, 80 and over | Maxillary Sinus Neoplasms - pathology | Paranasal Sinus Neoplasms - therapy | Nose Neoplasms - pathology | Head and Neck Neoplasms - diagnostic imaging | Tegafur - therapeutic use | Head and Neck Neoplasms - therapy | Nose Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Papilloma, Inverted - pathology | Head and Neck Neoplasms - pathology | Magnetic Resonance Imaging | Nasal Obstruction - etiology | Carcinoma, Squamous Cell - complications | Head and Neck Neoplasms - complications | Neoplasms, Multiple Primary - complications | Maxillary Sinus Neoplasms - therapy | Epistaxis - etiology | Maxillary Sinus Neoplasms - diagnostic imaging | Age Factors | Paranasal Sinus Neoplasms - diagnostic imaging | Carcinoma, Squamous Cell - diagnostic imaging | Papilloma, Inverted - diagnostic imaging | Neoplasms, Multiple Primary - diagnostic imaging | Chemoradiotherapy, Adjuvant | Fluorouracil - therapeutic use | Squamous Cell Carcinoma of Head and Neck | Nasal Cavity | Adult | Female | Retrospective Studies | Radiotherapy, Adjuvant | Papilloma, Inverted - complications | Kaplan-Meier Estimate | Otorhinolaryngologic Surgical Procedures | Neoplasms, Multiple Primary - pathology | Paranasal Sinus Neoplasms - complications | Disease-Free Survival | Maxillary Sinus Neoplasms - complications | Oxonic Acid - therapeutic use | Paranasal Sinus Neoplasms - pathology | Papilloma, Inverted - therapy | Aged | Neoplasm Staging | Drug Combinations | Medical records | Chemotherapy | Radiotherapy | College graduates | Cancer | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 11/2012, Volume 131, Issue 9, pp. 1969 - 1982
genital warts | screening | penile cancer | head and neck cancer | vulvar cancer | human papillomavirus | mortality | anal cancer | cervical cancer | incidence | HPV | vaccination | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Secondary Prevention | Papillomavirus Infections - therapy | Penile Neoplasms - epidemiology | Papillomaviridae - immunology | Vulvar Neoplasms - therapy | Head and Neck Neoplasms - epidemiology | Anus Neoplasms - therapy | Female | Anus Neoplasms - epidemiology | Uterine Cervical Neoplasms - therapy | Penile Neoplasms - therapy | Head and Neck Neoplasms - prevention & control | Papillomavirus Infections - complications | Primary Prevention | Early Detection of Cancer | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Head and Neck Neoplasms - therapy | Uterine Cervical Neoplasms - prevention & control | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Papillomavirus Vaccines - immunology | Medical colleges | Care and treatment | Vaccination | Oncology, Experimental | Research | College teachers | Prevention | Warts | Australians | Algorithms | Papillomavirus infections | Cervical cancer | Public health | Cancer | Human papillomavirus | Immunization | Infections | Disease | Medical screening | Index Medicus | head & neck cancer
Journal Article